Mirae Asset Global Investments
PNT

Mirae Asset Global Investments’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Mirae Asset Global Investments’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-64,680
Closed -$431K – 2630
2023
Q3 		$431K Buy
64,680
+482
+0.8% +$4.01K ﹤0.01% 1956
2023
Q2 		$580K Buy
64,198
+227
+0.4% +$2K ﹤0.01% 1872
2023
Q1 		$465K Buy
63,971
+33,267
+108% +$247K ﹤0.01% 1965
2022
Q4 		$224K Hold
30,704
– – ﹤0.01% 2263
2022
Q3 		$237K Buy
30,704
+9,520
+45% +$80.8K ﹤0.01% 2273
2022
Q2 		$144K Buy
+21,184
New +$162K ﹤0.01% 2245

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Mirae Asset Global Investments's PNT Position: Q4 2023 in Review

Mirae Asset Global Investments sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 64,680 shares — an estimated $431K sold.

Mirae Asset Global Investments first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $580K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Mirae Asset Global Investments reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 64,680 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $431K.
  • Mirae Asset Global Investments first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Mirae Asset Global Investments's POINT Biopharma Global Inc. Common Stock position peaked at $580K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Mirae Asset Global Investments's 13F filing for Q4 2023, filed 24 Jan 2024.